Latest News
IQE Shares Plunged 13.7% on Disappointing First Half Results, Falling Revenues
Shares of IQE plc (LON: IQE) plunged 13.7% after releasing disappointing financial results for the past six months of the year ended 30 June 2021. The company, which manufactur

Bit Digital (BTBT) Stock Edges Higher On Partnership With Blockfusion
Shares of bitcoin mining firm Bit Digital (NASDAQ: BTBT) have risen premarket on Tuesday after announcing a strategic co-mining agreement with Blockfusion USA. The agreement will see Blockfusion provide certain premises and services to Bit Digital

RenovoRx Stock Surges After Receiving New New 510(k) Clearance for its RenovoCath Delivery System
RenovoRx (NASDAQ: RNXT) shares are rallying premarket after the company said it has received a new 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its proprietary RenovoCath Delivery System. The RenovoCath Delivery System is

Orosur Mining (OMI) Shares Rally As JV Partner To Become Operator at the Anza Project
Orosur Mining (LON: OMI) shares jumped at the London open following the announcement that its Colombian Joint Venture partner, Minera Monte Águila SAS (Monte Águila), has elected to exercise its right to assume operatorship of the Anzá Project in Col

Power Metal Resources (POW) Sells Schreiber-Hemlo Interests, Shares Fall
Power Metal Resources (LON: POW), the London listed exploration company, has seen its shares fall on Tuesday after it confirmed the sale of its Schreiber-Hemlo project interests in Ontario, Canada, to First Class Metals Ltd. The sale is worth £1 m

Abingdon Health (ABDX) Shares Gain On Launch of Covid Semi-Quantitative Accessory
Abingdon Health shares are trading higher on Tuesday after the company launched a score-card product available alongside its AbC-19 rapid test. The score-card "provides a semi-quantitative result to indicate the strength of antibody response and p

Open Orphan (ORPH) Shares Gain as hVIVO Trial Reports Positive Results
Shares of pharmaceutical firm Open Orphan (LON: ORPH) are climbing after the company noted an announcement dated from Barvarian Nordic A/S (OMX: BAVA) reporting positive results from a human challenge study conducte

Shanta Gold (SHG) Shares Rallied 6.4% on Upbeat Phase II Drill Results From West Kenya
Shares of Shanta Gold Limited (LON: SHG) gapped 6.4% higher after releasing positive phase 2 drilling results from its West Kenya gold project. Today’s update was the sixth such operations update related to the West Kenya project. The gold mining

Marechale Capital (MAC) Shares Soared 118% on Weardale Lithium Fundraising
Marechale Capital Plc (LON: MAC) shares soared 118% after completing a fundraising round with Weardale Lithium Ltd ('WLL'), resulting in Marechale holding 8.7% of the lithium company’s outstanding shares. The corporate finance company’s shares sur

Ryanair Fail to Reach Agreement With Boeing For Max 10
Ryanair (LON: RYA) said on Monday that its negotiations with Boeing for a MAX10 order have ended without any pricing agreement. The airline said it will take delivery of over 200 B737 "Gamechanger" aircraft over the next 5 years from 2021 to 2025.

Challenger Energy (CEG) Shares Rise After Securing STOW Certification In Trinidad
Shares of Challenger Energy Group PLC (LON: CEG) edged higher today after receiving the Safe to Work in Trinidad &Tobago (STOW-TT) two-year certification showing that it had fully complied with Health, Safety and Environmental standards. The o

Tirupati Graphite (TGR) Shares Rallied 8.97% on New Graphite Production Setup
Shares of Tirupati Graphite PLC (LON: TGR) rallied 8.97% after installing and commissioning the first 9,000 tpa flake graphite module at its Vatomina Project located in Madagascar. The company noted that its latest achievement was a step in the ri

Digital 9 Infrastructure (DGI9) Shares Fall On £231m Acquisition of Data Centre Platform
Digital 9 Infrastructure (LON: DGI9) shares have fallen after the company confirmed it has completed the acquisition of Verne Holdings Limited, a data centre platform in Iceland, for £231 million.

Wishbone Gold (WSBN) Shares Edge Higher After Signing Land Access Agreement
Shares of Wishbone Gold (LON: WSBN) are trading higher on Monday after the company announced a Land Access Agreement with the Western Desert Lands Aboriginal Corporation (WDLAC) acting on behalf of the Martu people. Wishbone has properties in the

Powerhouse Energy (PHE) Shares Surge After Addressing Press Speculation
Powerhouse Energy (LON: PHE) shares have surged over 20% on Monday after the company addressed speculation about a potential partnership between DMG licensee Hydrogen Utopia International (HUI) and Linde that would see Linde deploy its DMG waste plas

Omega Diagnostics (ODX) Shares Rise After Filing CE Mark Documentation
Omega Diagnostics (LON: ODX) shares are climbing on Monday after the company said it has filed the supporting data and documentation relating to its submission for CE marking for self-test use for the VISITECT COVID

FuboTV Stock Rises Premarket After Receiving Gaming Licence to Offer Mobile Event Wagering in Arizona
FuboTV (NYSE: FUBO) shares are climbing premarket after announcing that its subsidiary, Fubo Gaming, has been granted a Management Services Provider Certification from the Arizona Department of Gaming (ADG).

Falcon Oil & Gas (FOG) Shares Soared 112.4% on Positive Production Test Results
Falcon Oil & Gas Ltd (LON: FOG) shares soared 112.4% after announcing positive test results at its Amungee NW-1H well located in the Beetaloo Sub-basin, Northern Australia.

Symphony Environmental (SYM) Shares Rallied 7.74% on Health Canada’s Approval
Shares of Symphony Environmental Technologies plc (LON: SYM) rallied 7.74% after announcing that Health Canada had approved its d2p masterbatch packaging material for use in bread packaging within Canada. The company noted that today’s approval ca

Forte Biosciences Stock Plunges 80% As FB-401 Fails to Meet Statistical Significance
Forte Bioscience (NASDAQ: FBRX) shares have dropped over 80% premarket after the company said topline data from its Phase 2 clinical trial of FB-401 for treating atopic dermatitis failed to meet statistical significance for the primary endpoint. T
